U.S. markets open in 4 hours 12 minutes

Aleafia Health Announces Election of Directors

TORONTO, June 30, 2020 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (the “Company”) (AH.TO) (OTC: ALEAF) is pleased to announce the results of the vote on the election of directors at its annual and special meeting of shareholders held on June 30, 2020 (the “Meeting”). All six nominees set out in the management information circular of the Company dated May 20, 2020 were elected as directors of the Company to hold office until the next annual meeting of shareholders or until their successors are elected or appointed.  The voting results based on the ballots cast are:

Nominee Votes in Favour Votes in Favour as a Percentage of Votes Cast Votes Withheld Votes Withheld as a Percentage of Votes Cast
Lea M. Ray 57,533,952 84.55% 10,509,482 15.45%
Mark Sandler 62,326,722 91.60% 5,716,712 8.40%
Daniel Milliard 55,570,300 81.67% 12,473,134 18.33%
Loreto Grimaldi 52,645,676 77.37% 15,397,758 22.63%
Rhonda Lawson 67,304,425 98.91% 739,009 1.09%
Glenn Washer 67,395,225 99.05% 648,209 0.95%
         

Shareholders also voted in favour of all resolutions put forth by the Company at the Meeting. Final voting results on all matters will be filed on the Company’s SEDAR profile at www.sedar.com.

For Investor & Media Relations

Nicholas Bergamini, VP Investor Relations
1-833-879-2533
IR@AleafiaHealth.com

Learn More: www.AleafiaHealth.com

About Aleafia Health

Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada and in international markets. The Company operates medical clinics, education centres and production facilities for the production and sale of cannabis.

Aleafia Health owns three significant licensed cannabis production facilities, including the first large-scale, legal outdoor cultivation facility in Canadian history. The Company produces a diverse portfolio of commercially proven, high-margin derivative products including oils, capsules and sprays. Aleafia Health operates the largest national network of medical cannabis clinics and education centres staffed by MDs, nurse practitioners and educators and operates internationally in three continents.

Innovation, the heart of Aleafia Health’s competitive advantage, has led to the Company maintaining a medical cannabis dataset with over 10 million data points to inform proprietary illness-specific product development and its highly differentiated education platform FoliEdge Academy. The Company is committed to creating sustainable shareholder value; the TSX Venture Exchange named Aleafia the 2019 top performing company prior to its graduation to the TSX.

Forward Looking Information

This news release contains forward-looking information within the meaning of applicable Canadian and United States securities laws and are expressly qualified by this cautionary statement. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements in this news release include, but are not limited to, statements with respect to injection of value this settlement brings to the Company’s business. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including risks contained in the Company’s annual information form dated March 18, 2020 which is available on the Company’s SEDAR profile at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release is made as of the date of this news release and the Company does not undertake any obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.